Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jun;31(6):860-4.
doi: 10.1128/AAC.31.6.860.

Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function

Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function

G L Drusano et al. Antimicrob Agents Chemother. 1987 Jun.

Abstract

We examined the pharmacokinetic behavior of 200 mg of ciprofloxacin administered intravenously to 32 volunteers whose renal function as measured by creatinine clearance ranged from 0 to 8.99 liters/h per 1.73 m2. Serum clearances (mean +/- standard deviation) were 26.8 +/- 5.7 and 15.4 +/- 4.3 liters/h per 1.73 m2 in normal and anephric volunteers, respectively. The half-life (mean +/- standard deviation) increased from 4.3 +/- 0.8 h in normal volunteers to 8.6 +/- 3.3 h in anephric volunteers. There was good correlation between normalized creatinine clearance and both normalized serum and renal clearance. The regression equation for serum clearance (CLS) versus creatinine clearance (CLCR) was CLS = 1.97 X CLCR + 13.23, where r = 0.697; for renal clearance versus creatinine clearance, the equation was CLR = 2.26 X CLCR, where r = 0.845. On the basis of these data, we recommend a maximum 50% reduction in dose when ciprofloxacin is instituted at a renal function of 1.2 to 1.8 liters/h per 1.73 m2 (20 to 30 ml/min per 1.73 m2). Because of the observed variation in ciprofloxacin half-life in our anephric volunteers, we also recommend that a schedule of administration every 12 h be maintained, even for patients without urine output.

PubMed Disclaimer

References

    1. Comput Programs Biomed. 1979 Mar;9(2):115-34 - PubMed
    1. Antimicrob Agents Chemother. 1984 Mar;25(3):331-5 - PubMed
    1. Antimicrob Agents Chemother. 1986 Sep;30(3):444-6 - PubMed
    1. Antimicrob Agents Chemother. 1986 Jul;30(1):152-6 - PubMed
    1. Antimicrob Agents Chemother. 1986 Sep;30(3):440-3 - PubMed

Publication types